Trial intelligence / Profile preview

Fluvastatin in DCIS or Stage I Breast Cancer

NCT00416403Phase 2Completed

Sponsor
University of California, San Francisco
Start
Jul 2006
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluvastatin in breast cancer, ductal carcinoma in situ (DCIS), sponsored by University of California, San Francisco. Started Jul 2006; status: completed.

02

Drugs

fluvastatin
03

Conditions

breast cancerductal carcinoma in situ (DCIS)

Beyond the preview

Go deeper on NCT00416403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00416403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call